Health Care Services

MODIVCARE INC

MODIVCARE INC released FY2025 Q2 earnings on December 29 (EST), actual revenue USD 659.55 M (forecast USD 650.74 M), actual EPS USD -21.1599

MODIVCARE INC released FY2025 9 Months Earnings on December 29 (EST), actual revenue USD 1.99 B, actual EPS USD -29.7599

MODIVCARE INC released FY2025 Q3 earnings on December 29 (EST), actual revenue USD 679.71 M (forecast USD 666.01 M), actual EPS USD -5.0799

MODIVCARE INC released FY2024 Q1 earnings on May 9 After-Market EST, actual revenue USD 684.45 M (forecast USD 663.86 M), actual EPS USD -1.5702

MODIVCARE INC released FY2025 Q1 earnings on May 9 After-Market EST, actual revenue USD 650.65 M (forecast USD 644.87 M), actual EPS USD -3.52

MODIVCARE INC released FY2023 earnings on March 6 After-Market EST, actual revenue USD 2.751 B (forecast USD 2.748 B), actual EPS USD -14.43

MODIVCARE INC released FY2023 Q4 earnings on March 6 After-Market EST, actual revenue USD 702.83 M (forecast USD 696.73 M), actual EPS USD -0.374

MODIVCARE INC released FY2024 Q4 earnings on March 6 After-Market EST, actual revenue USD 702.8 M (forecast USD 703.3 M), actual EPS USD -1.6482

MODIVCARE INC released FY2024 annual earnings on March 6 After-Market EST, actual revenue USD 2.788 B (forecast USD 2.788 B), actual EPS USD -14.14

MODIVCARE INC released FY2022 Annual Earnings on March 6 Pre-Market (EST), Actual Revenue: USD 2.504 B (Forecast: USD 2.471 B), Actual EPS: USD -2.2618

MODIVCARE INC released FY2024 Q3 earnings on November 7 After-Market EST, actual revenue USD 702.04 M (forecast USD 711.28 M), actual EPS USD -1.8699

MODIVCARE INC released FY2023 Q3 earnings on November 7 After-Market (EST), actual revenue USD 686.93 M (forecast USD 699.2 M), actual EPS USD -0.3033

MODIVCARE INC released FY2024 9 Months Earnings on November 7 After-Market EST, Actual Revenue USD 2.085 B, Actual EPS USD -12.5102

MODIVCARE INC released FY2023 Semi-Annual Earnings on August 8 After-Market EST, Actual Revenue: USD 1.361 B, Actual EPS: USD -13.7618

MODIVCARE INC released FY2023 Q2 earnings on August 8 After-Market (EST), actual revenue USD 699.11 M (forecast USD 652.77 M), actual EPS USD -13.4746

MODIVCARE INC released FY2024 Semi-Annual earnings on August 8 After-Market EST, actual revenue USD 1.383 B, actual EPS USD -10.6399

MODIVCARE INC released FY2024 Q2 earnings on August 8 After-Market EST, actual revenue USD 698.3 M (forecast USD 701 M), actual EPS USD -9.07

Fusemachines

Erayak Power Solution

Smart Powerr

Sky Quarry

Cue BioPharma

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

ZeZentalis Pharma

XCF Global

Rackspace Tech

U Power

信诺保险

BrightSpring Health Services - Unit

费森尤斯(ADR)

实验美控

奎斯特诊疗

BrightSpring Health Services

Chemed

拜尔斯普保健

Hims & Hers Health

Billiontoone

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

MODIVCARE INC(MODVQ.US)

MODIVCARE INC Stock Performance Chart